Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

CepTor plans IND for Myodur, seeks orphan drug designation

Oct. 17, 2005

Ebixa receives European approval for moderate Alzheimer's disease

Oct. 14, 2005

Japan approves fluvoxamine maleate for social anxiety disorder

Oct. 14, 2005

A-317567 -- First blocker of ASICs implicated in pain pathways

Oct. 14, 2005

5-HT3 receptor antagonists suppress beta-amyloid-induced neurotoxicity

Oct. 14, 2005

Eisai and TorreyPines sign new Alzheimer's research agreement

Oct. 14, 2005

Anti-Alzheimer's effect of statins may be mediated via antiinflammatory effects on microglia

Oct. 14, 2005

Eszopiclone shows efficacy in insomnia associated with menopause

Oct. 13, 2005

Cannabis-based medicine reduces central pain scores in MS patients

Oct. 13, 2005

Alpharma to study abuse-resistant extended-release opioid in phase II study

Oct. 13, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...